HHS moves to loosen limits on compounded peptide shots
Published
HHS sent the White House a plan that would let pharmacies temporarily make some popular peptides, including BPC-157, which FDA had called too risky to compound. FDA staff say none have been proven safe or effective in people. Be cautious with online peptide offers.
Source: STAT
This is a plain-language summary. Read the original source for full details.